A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).
Epistemonikos ID: ce31b9f68eef34c27c9c0c01cd4626edf465c74a
First added on: May 09, 2024